Recently, American recommendations on surveillance in childhood with hereditary pheochromocytomas and PGLs have been published [15], in which a specific surveillance protocol is recommended for SDH mutation carriers (irrespective of mutation type). This evidence concerns the gene SDHB and hereditary pheochromocytoma-paraganglioma.